Advertising

The Planning Shop joins Omnicom

The London healthcare brand and research agency will be part of Omnicom's DAS Group.

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

OPDP says phentermine site thin on details

OPDP says phentermine site thin on details

By

The bad-ad watchdog says the promotional website for the weight-loss medication Suprenza leaves out too much information.

FDA examines DTC close up

FDA examines DTC close up

By

The regulator's latest study will use eye-tracking tools.

OPDP takes on sales aid for alcohol drug

OPDP takes on sales aid for alcohol drug

By

The advertising watchdog gave drugmaker Alvogen 15 days to make amends.

Publicis, Facebook ink deal

The Omnicom-Publicis deal may have been scuttled, but the hunger for deals remains.

Takeda admits running bad ads

The company said it used "inappropriate expressions" in promotions of a blood pressure medication.

Raid at Novartis Tokyo

The reason: Diovan.

FDA may ditch some TV ad requirements

A consumer survey will shape the regulator's position.

Google ads target off-limits Canadians

Canada's Office of the Privacy Commissioner says the search giant failed to protect what qualifies as sensitive user information.

New owner to publish MedAdNews biannually

New owner to publish MedAdNews biannually

By

A month after UBM Canon closed the B2B magazine, marketing firm Outcomes LLC announced its return to twice-a-year publication.

FTC wants media to be wary of ads

The agency says outlets need to rethink running ads that make false claims.

Japan lodges complaint against Novartis

The Health Ministry alleges Novartis exaggerated advertising for its blood pressure drug Diovan.

The year's most popular stories

The year's most popular stories

Our year-end list captures the 10 that sparked heaviest interest.

Draft legislation has advertisers on edge

Draft legislation has advertisers on edge

By

Lobbying groups say the ad tax draft proposal could wreak havoc throughout the ad industry and its partners, such as publishers and broadcasters, if it were to go through.

UK, Brazilian ads take top honors at Globals

UK, Brazilian ads take top honors at Globals

An organ-donation campaign with a Brazilian football tie-in, and a UK managed-access company's series of documentary films, took top honors.

Ariad hunkers down

Ariad hunkers down

By

The drugmaker's latest financial plans could power it through mid-2015.

TV interviews trigger Aegerion warning letter

TV interviews trigger Aegerion warning letter

By

The FDA's Bad Ad group says the drugmaker misbranded its cholesterol drug during interviews on CNBC.

WebMD is bringing former advertisers back on board

WebMD is bringing former advertisers back on board

By

The company says it recaptured some former advertisers and that third-quarter traffic is up compared with last year.

FDA peers into teenage brain

The regulator will study how teens perceive ads and if targeted media needs unique standards.

Intouch creates HCP content division

Intouch creates HCP content division

By

Growing client demand encouraged the agency to make its HCP content capabilities official.

Valeant leverages Rx sales force, YouTube for OTC brand

Valeant leverages Rx sales force, YouTube for OTC brand

By

The company is supporting its professional pitch for the acne drug with a micro-targeted marketing strategy.

Business briefs: Eisai, AHRQ, mWellnesss

Eisai uses a lawsuit to prompt the DEA, AHRQ gets a new director, mWellness runs into adherence issues.

AMA to shutter newspaper amid ad turmoil

AMA to shutter newspaper amid ad turmoil

By

American Medical News' 55-year publishing run will come to a close this year, the AMA, its publisher, said today.

Dendreon lowers expectations, touts DTC effort

By

The company narrowed its second quarter loss, but said its national TV campaign is driving an uptick in consumer interest.

WebMD caps search, chooses in-house CEO Schlanger

WebMD caps search, chooses in-house CEO Schlanger

By

David Schlanger is the company's new chief executive, a role he's filled on an interim basis since May.

Merz web-copy shortcuts don't sit well with OPDP

By

FDA's Office of Prescription Drug Promotion issued an Untitled Letter over what it says are misleading copy and overstated efficacy claims online.

Astellas serves up dose of "reality" in DTC effort

Astellas serves up dose of "reality" in DTC effort

By

The drug maker's broadcast-heavy "OAB reality" campaign stresses the emotional toll on women.

J&J painkiller probe expands scrutiny of industry marketing

By

HHS is looking into how J&J marketed opioid painkiller Nucynta, adding to the firm's list of investigations and those of the industry as a whole.

Genetic testing firm airs TV spot as part of $5M ad buy

Genetic testing firm airs TV spot as part of $5M ad buy

By

23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.